Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2

Author： Weecharangsan Wanlop   Lee Robert J.  

Publisher： Informa Healthcare

ISSN： 1521-0464

Source： Drug Delivery, Vol.19, Iss.6, 2012-08, pp. : 292-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Co-delivery of Plasmid DNA and Antisense Oligodeoxyribonucleotide into Human Carcinoma Cells by Cationic Liposomes

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 9, 2014-09 ,pp. : 790-799

Bentham Science Publishers

Access to resources Recommend Favorite

Bcl-2 Antisense in the Treatment of Human Malignancies: A Delusion in Targeted Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 6, 2007-12 ,pp. : 373-381

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of drug binding to human serum albumin by cholecystographic agents

By Bertucci C.   Cimitan S.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 901-908

Elsevier

Access to resources Recommend Favorite

Hydrolysis of carbaryl by human serum albumin

By Sogorb Miguel   Carrera Victoria   Vilanova Eugenio  

Archives of Toxicology, Vol. 78, Iss. 11, 2004-11 ,pp. : 629-634

Springer Publishing Company

Access to resources Recommend Favorite

Chemosensitization by Antisense Oligonucleotides Targeting MDM2

By  

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-01 ,pp. : 51-56

Bentham Science Publishers

Access to resources Recommend Favorite